Navigation Links
Cell Therapeutics Initiating Rolling NDA Submission for Pixantrone
Date:4/14/2009

CTI to Request Priority Review

SEATTLE, April 14 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that it began a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for pixantrone to treat relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL). CTI expects to complete the submission this quarter and will request priority review which if granted could lead to an approval decision from the FDA in Q4 2009.

"This is a significant milestone for CTI as we move pixantrone closer to addressing a truly significant unmet medical need for relapsed or refractory aggressive NHL patients," said James A. Bianco, M.D., CEO of CTI. "The commercialization of pixantrone will drive shareholder value as a result of the large market potential for this product. We believe that the recent significant investment in CTI by a single institutional investor reflects a growing interest in CTI and in particular in pixantrone by the investment community. With added financial resources, CTI can advance pixantrone through the NDA review process while we continue our progress on strategic business development opportunities and relationships."

CTI previously announced that its pivotal phase III (PIX 301) EXTEND trial had achieved its primary endpoint with patients randomized to treatment with pixantrone achieving a significantly higher rate of confirmed (CR) and unconfirmed complete remissions (CRu) compared to patients treated with standard chemotherapy (14/70 (20.0%) for pixantrone arm compared to 4/70 (5.7%) for the standard chemotherapy arm, p = 0.02) with no patients in the standard chemotherapy arm achieving a confirmed complete remission. Additionally, progression-free survival (PFS) results from this study show patients treated with pixantrone experienced a statistically significant improvement in median progression-free survival, compar
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Former Executive at Genzyme Corp. and Osiris Therapeutics, Inc. to Head Business Advisory Board at Rx for Africa, Inc.
2. Rheumatoid Arthritis Therapeutics in Taiwan
3. Rheumatoid Arthritis Therapeutics in China
4. Global Therapeutics Manufacturer Selects TrackWise(R) to Reduce the Cost of Compliance
5. Rheumatoid Arthritis Therapeutics in Philippines
6. Rheumatoid Arthritis Therapeutics in Thailand
7. Frost & Sullivan: Rheumatoid Arthritis Therapeutics in Malaysia
8. Orexigen(R) Therapeutics Names Michael Narachi, 24-Year Biopharmaceutical Veteran, New President and Chief Executive Officer
9. Medarex Highlights Oncology Pipeline at Needham Cancer Therapeutics Conference in New York City
10. Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
11. Transition Therapeutics Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... According to the ... is legal, and are exposed to advertisements, for medicinal use are more likely to ... settings where the use of marijuana is considered beneficial are more apt to use ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... on the therapeutic development for Atherosclerosis. Atherosclerosis is a slow, progressive disease that ... and MOAs to produce first-in-class and best-in-class products. Complete report on Atherosclerosis Pipeline ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the ... expiring November 30, 2019, during its recent meeting. , The Commission received renewal ... program’s compliance with the NCCA’s Standards for the Accreditation of Certification Programs. ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Southwest Michigan, changed its name in July to Kalamazoo Strength & Conditioning. , ... http://www.kalamazoosc.com , and “reflects the evolution of our training center over the past ...
(Date:7/29/2015)... ... ... Today marks a significant achievement in bringing new monies into early stage companies. ... a group of experienced investors, has tapped into an investor community passionate about Sofia’s ... part of the fund. The Sofia Fund II is now closed to investors, ...
Breaking Medicine News(10 mins):Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3Health News:Atherosclerosis Pipeline Assessment Review H1 2015 Market Research Report Available at RnRMarketResearch.com 4Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Sofia Fund Surpasses Investor Goals 2
... , FLINT, Mich., Nov. 30 HealthPlus of Michigan today ... plans designed for Medicare-eligible people looking for affordable benefit choices ... Medicare plans are the highest-ranked Medicare plans in Michigan, according ... U.S. News & World Report and the National Committee on ...
... , - Product revenues increase by ... VANCOUVER, Nov. 30 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today ... 2009 (all figures are in US dollars): , For the three ... of $429,860 compared to a net loss of $993,211 for the ...
... , WASHINGTON, Nov. 30 At a briefing of ... for Citizens with Disabilities (CCD) today, Howard Bedlin, Vice President ... to ensure that health care reform legislation responds to the ... families. , "Millions of seniors, after working hard all their ...
... , , ATLANTA, Nov. ... "Thin-Client EHR Initiative," with national recognition as one of ... Led by Chief Technical Architect, Mark Blomquist, Kool Smiles built a ... 13 new dental offices across the United States. With this ...
... , "This epidemic ... become infected with HIV, and two million die from AIDS-related diseases." ... the Global AIDS Alliance (GAA) calls on President Obama and his ... Health Organization (WHO) showing that the AIDS pandemic continues to be ...
... 30 Major League Baseball,s Mark Teahen, longtime third ... Chicago White Sox, will receive the 2009 Hutch Award(®). The award ... exemplifies the honor, courage and dedication of baseball great Fred Hutchinson, ... 28-year-old Redlands, Calif., native made his MLB debut with the Royals ...
Cached Medicine News:Health News:HealthPlus Launches New Medicare Advantage Plans 2Health News:HealthPlus Launches New Medicare Advantage Plans 3Health News:CRH Medical reports Q3 2009 results 2Health News:CRH Medical reports Q3 2009 results 3Health News:NCOA, Bedlin Brief Leading Aging Organizations on Health Care Reform, Needed Long-Term Care Provisions 2Health News:Kool Smiles Named Among 2009 InfoWorld 100 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 2Health News:GAA Calls on President Obama to Act on the Reality of AIDS 3Health News:Mark Teahen Named 2009 Hutch Award Winner 2
(Date:7/29/2015)... BERKELEY, Calif. , July 29, 2015 ... member of the Daiichi Sankyo Group, announced today that ... published clinical trial results demonstrating that the investigational drug, ... regressions in most patients with tenosynovial giant cell tumor ... or tendon sheath. Following phase 1 dose-escalation, ...
(Date:7/29/2015)... Pa. , July 29, 2015 ... UNS), a developer, manufacturer and supplier of injectable ... the Imperium™ platform of instant patch pumps for ... disposable, multi-day wearable insulin pump that does not ... it is prefilled and pre-assembled like an insulin ...
(Date:7/29/2015)... , July 29, 2015 Varian Medical Systems, ... through one of its European subsidiaries, agreed to acquire ... of components and subsystems for X-ray imaging equipment manufacturers. Varian,s ... pay approximately €50 million in cash for Claymount. The ... Claymount is one of the world,s leading ...
Breaking Medicine Technology:Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5Unilife Introduces World's First Instant Patch Pump for Insulin 2Unilife Introduces World's First Instant Patch Pump for Insulin 3Unilife Introduces World's First Instant Patch Pump for Insulin 4Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 2Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 3Varian Medical Systems Acquiring Claymount to Expand Imaging Components Portfolio 4
... Caliper Life Sciences, Inc. (Nasdaq: CALP ) ... DNA assay for its LabChip GX analytical platform, as ... GX assay is optimized for QC steps that assess ... libraries. The Sciclone NGS Workstation automates the most commonly ...
... Collagen Matrix, Inc., the leader in collagen- and ... its operations by the addition of a 28,000 sq. ... 07436. The company will be relocating the ... warehouse, and the administrative group to the newly renovated ...
Cached Medicine Technology:Caliper Life Sciences Expands Offering for Next Generation Sequencing Workflows 2Collagen Matrix, Inc. Expands Operations and Moves Corporate Headquarters to Oakland, New Jersey 2
This instrument measures intraocular pressure without,contacting. Alignment is performed semi-automatically....
... VK-2 is a professional digital imaging system ... features you need to acquire, analyze, and ... the tools you use the most are,available ... results quickly and easily. This high-resolution system ...
The convenience of safe and precise Patient Controlled Analgesia in a flexible system designed with advanced technology. This is progressive, innovative, and effective pain management in a sophistica...
... Ipump Pain Management System answers the ... with one-on-one flexibility. From programming to ... customizable pain management right where you ... is designed to help each patient ...
Medicine Products: